7 foods that can enhance the effects of exercise
Exercise enhancing food 1: Easily digestible fruit
Fruit is nature’s answer to a healthy sugar high, and it provides carbohydrates to boost your energy levels. Fresh fruit such as bananas and apples are loaded with vitamin C, antioxidants, and fibre, making this a fantastic way to give you a natural boost of energy before your workout. Make sure you opt for easily digestible fruit as those that are hard to digest – such as those from the citrus family – could hinder your exercise by causing stomach cramps.
Exercise enhancing food 2: Greek yoghurt
Greek yoghurt is a great pre-workout treat as it contains twice the protein than normal yoghurt and provides you with good carbs, which are beneficial for exercise energy requirements. The combination of protein and carbohydrates in yoghurt are also great for muscle growth. Add in a few of your favourite tasty berries for extra nutrition and a natural energy boost.
Exercise enhancing food 3: Bran cereals
Bran cereals are a winning choice when it comes to enhancing physical performance. They are high in fibre and the betaine chemical found in bran foods enhances your physical performance and boosts your metabolic rate. Bran also helps with cell function and prevents dehydration during exercise. For a healthy, pre-exercise breakfast, fuel your body with bran flakes topped with fruit to get half your recommended daily serving of fruit and whole grain before you’ve even had chance to change out of your pyjamas.
Exercise enhancing food 4: Chicken
For up to one hour after exercise, your body will be craving the nutrients it has lost, so this is the most important time to replenish your body and re-build your depleted muscles. Eating protein such as chicken, eggs or fish will provide your muscles with amino acids that help them to grow back stronger and bigger, so it’s essential that you’re consuming protein-rich foods to enhance the effects of your workout.
Exercise enhancing food 5: Liquid meals
Liquid meals such as smoothies and nutrient-rich shakes allow you to get all the essential post-exercise nutrients in just a few gulps, making this the perfect way to provide your body with essential nutrients in the one hour post-exercise recovery period. Most people find the thought of a big meal daunting after exercise, so topping up on essential muscle-repairing nutrients in liquid form is a quick and easy way for your body to access these useful nutrients. Plus, the faster these nutrients enter your body the more successful you will be in building muscle and recovering from your workout.
Exercise enhancing food 6: Oatmeal
Oats are your best friend when it comes to prepping your muscles for a workout, as they provide glucose to fuel your muscles. Oats are also a great choice for losing weight, as they encourage the body to burn fat quicker in order to fuel your muscles. Try oatmeal pancakes around three hours before exercise for a tasty treat that is sure to enhance the effects of your workout by slowly releasing sugar, ultimately keeping energy levels on an even keel during your workout.
Exercise enhancing food 7: Trail mix
Nibbling on trail mix is an excellent way to top up on the minerals lost during exercise. Indeed, a well-prepared trail mix includes a well-rounded mix of nutrients that are essential for maintaining optimum energy levels throughout your workout. Trail mix provides protein too, which is essential for building muscles and prolonging optimum energy levels so this is the perfect go-to snack before, during, and after your exercise.
The challenges to vaccine distribution affecting everyone
While it is comforting to know that vaccines against COVID-19 are showing remarkable efficacy, the world still faces intractable challenges with vaccine distribution. Specifically, the sheer number of vaccines required and the complexity of global supply chains are sure to present problems we have neither experienced nor even imagined.
Current projections estimate that we could need 12-15 billion doses of vaccine, but the largest vaccine manufacturers produce less than half this volume in a year. To understand the scale of the problem, imagine stacking one billion pennies – you would have a stack that is 950 miles high. Now, think of that times ten. This is a massive problem that one nation can’t solve alone.
Even if we have a vaccine – can we make enough? Based on current projections, Pfizer expects to produce up to 1.3 billion doses this year. Moderna is working to expand its capacity to one billion units this year. Serum Institute of India, the world’s largest vaccine producer, is likely to produce 60% of the 3 billion doses committed by AstraZeneca, Johnson & Johnson and Sanofi. This leaves us about 7 billion doses short.
Expanding vaccine production for most regions in the world is complicated and time-consuming. Unlike many traditional manufacturing operations that can expand relatively quickly and with limited regulation, pharmaceutical production must meet current good manufacturing practice (CGMP) guidelines. So, not only does it take time to transition from R&D to commercial manufacturing, but it could also take an additional six months to achieve CGMP certification.
The problem becomes even more complex when considering the co-products required. Glass vials and syringes are just two of the most essential co-products needed to produce a vaccine. Last year, before COVID-19, global demand for glass vials was 12 billion. Even if it is safe to dispense ten doses per vial, there is certain to be significant pressure on world supply of the materials needed to package and distribute a vaccine.
It is imperative drug manufacturers and their raw material suppliers have clear visibility of production plans and raw material availability if there is any hope of optimizing scarce resources and maximising production yield.
It is widely known by now that temperature is a critical factor for the COVID-19 vaccine. Even the regions with the most developed logistics infrastructures and resources needed to support a cold-chain network are sure to struggle with distribution.
For the United States alone, State and local health agencies have determined distribution costs will exceed $8.4 billion, including $3 billion for workforce recruitment and training; $1.2 billion for cold-chain, $1 billion vaccination sites and $0.5 billion IT upgrades.
The complexity of the problem increases further when considering countries such as India that do not have cold-chain logistics networks that meet vaccine requirements. Despite India’s network of 28,000 cold-chain units, none are capable of transporting vaccines below -25°Celsius. While India’s Serum Institute has licensed to manufacture AstraZeneca’s vaccine, which can reportedly be stored in standard refrigerated environments, even a regular vaccine cold chain poses major challenges.
Furthermore, security will undoubtedly become a significant concern that global authorities must address with a coordinated solution. According to the Pharmaceutical Security Institute, theft and counterfeiting of pharmaceutical products rose nearly 70% over the past five years. As with any valuable and scarce product, counterfeits will emerge. Suppliers and producers are actively working on innovative approaches to limit black-market interference. Corning, for example, is equipping vials with black-light verification to curb counterfeiting.
Clearly, this is a global problem that will require an unprecedented level of collaboration and coordination.
Disconnected information systems
While it is unreasonable to expect every country around the world will suddenly adopt a standard technology that would provide immediate, accurate and available information for everyone, it is not unreasonable to think that we can align on a standard taxonomy that can serve as a Rosetta Stone for collaboration.
A shared view of the situation (inventory, raw materials, delivery, defects) will provide every nation with the necessary information to make life-saving decisions, such as resource pooling, stock allocations and population coverage.
By allowing one central authority, such as the World Health Organization, to organize and align global leaders to a single collaboration standard, such as GS1, and a standard sharing protocol, such as DSCSA, then every supply chain participant will have the ability to predict, plan and execute in a way that maximises global health.
Political influence and social equality
As if we don’t have enough stress and churn in today’s geopolitical environment, we must now include the challenge of “vaccine nationalism.” While this might not appear to be a supply chain problem, per se, it is a critical challenge that will hinge on supply chain capabilities.
In response to the critical supply issues the world experienced with SARS-CoV-2, the World Health Organization, Gavi, the Vaccine Alliance and the Coalition for Epidemic Preparedness Innovations (CEPI) formed Covax: a coalition dedicated to equitable distribution of 2 billion doses of approved vaccines to its 172 member countries. Covax is currently facilitating a purchasing pool and has made commitments to buy massive quantities of approved vaccines when they become available.
However, several political powerhouse countries, such as the United States and Russia, are not participating. Instead, they are striking bilateral deals with drug manufacturers – essentially, competing with the rest of the world to secure a national supply. Allocating scarce resources is never easy, but when availability could mean the difference between life and death, it becomes almost impossible.
Global production, distribution and social equality present dependent yet conflicting realities that will demand global supply chains provide complete transparency and an immutable chain of custody imperative to vaccine distribution.
The technology is available today – we just need to use it. We have the ability to track every batch, pallet, box, vile and dose along the supply chain. We have the ability to know with absolute certainty that the vaccine is approved, where and when it was manufactured, how it was handled and whether it was compromised at any point in the supply chain. Modern blockchain technologies should be applied so that every nation, institution, regulator, doctor and patient can have confidence in knowing that they are making an impact in eradicating COVID-19.